James E. Dahlman

12.8k total citations · 7 hit papers
76 papers, 7.3k citations indexed

About

James E. Dahlman is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, James E. Dahlman has authored 76 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Molecular Biology, 14 papers in Cancer Research and 7 papers in Immunology. Recurrent topics in James E. Dahlman's work include RNA Interference and Gene Delivery (51 papers), Advanced biosensing and bioanalysis techniques (25 papers) and CRISPR and Genetic Engineering (12 papers). James E. Dahlman is often cited by papers focused on RNA Interference and Gene Delivery (51 papers), Advanced biosensing and bioanalysis techniques (25 papers) and CRISPR and Genetic Engineering (12 papers). James E. Dahlman collaborates with scholars based in United States, Netherlands and United Kingdom. James E. Dahlman's co-authors include Róbert Langer, Kalina Paunovska, David Loughrey, Mark W. Tibbitt, Daniel G. Anderson, Melissa P. Lokugamage, Cory D. Sago, Tyler Jacks, Avi Schroeder and Monte M. Winslow and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

James E. Dahlman

74 papers receiving 7.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Treating metastatic cancer with nanotechnology

2011 952 citations James E. Dahlman, Róbert Langer et al. profile →
Drug delivery systems for RNA therapeutics

2022 867 citations Kalina Paunovska, David Loughrey et al. profile →
Emerging Frontiers in Drug Delivery

2016 781 citations James E. Dahlman, Róbert Langer et al. Journal of the American Chemical Society profile →
Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs

2021 357 citations Melissa P. Lokugamage, Daryll Vanover et al. profile →
Proliferation and Recruitment Contribute to Myocardial Macrophage Expansion in Chronic Heart Failure

2016 328 citations James E. Dahlman, Daniel G. Anderson et al. profile →
Piperazine-derived lipid nanoparticles deliver mRNA to immune cells in vivo

2022 130 citations Huanzhen Ni, Marine Z. C. Hatit et al. Nature Communications profile →
Drug delivery systems for CRISPR-based genome editors

2023 98 citations Victoria J. Madigan, Feng Zhang et al. Nature Reviews Drug Discovery profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
James E. Dahlman	5.0k	1.5k	1.4k	795	694	76	7.3k
Qiang Cheng	5.4k 1.1×	1.2k 0.8×	1.2k 0.9×	850 1.1×	413 0.6×	86	6.9k
Roy van der Meel	5.6k 1.1×	1.9k 1.2×	1.8k 1.3×	1.1k 1.3×	964 1.4×	51	7.9k
Gaurav Sahay	5.7k 1.1×	1.8k 1.2×	2.1k 1.5×	810 1.0×	474 0.7×	69	8.4k
Dominik Witzigmann	6.2k 1.2×	2.0k 1.3×	2.3k 1.7×	1.0k 1.3×	545 0.8×	64	9.1k
Tuo Wei	4.6k 0.9×	1.9k 1.2×	1.8k 1.3×	683 0.9×	304 0.4×	68	7.1k
Jayesh A. Kulkarni	5.8k 1.2×	1.1k 0.7×	1.0k 0.7×	995 1.3×	490 0.7×	47	7.2k
Yongxiang Zhao	3.7k 0.7×	2.1k 1.4×	797 0.6×	951 1.2×	864 1.2×	200	7.3k
Yuanyu Huang	5.7k 1.1×	2.1k 1.4×	1.4k 1.0×	836 1.1×	1.1k 1.6×	152	8.0k
Enrico Mastrobattista	4.4k 0.9×	1.4k 0.9×	1.7k 1.3×	877 1.1×	322 0.5×	137	6.9k
Daniel J. Siegwart	7.3k 1.5×	2.2k 1.5×	2.6k 1.9×	1.2k 1.6×	717 1.0×	98	12.1k

Countries citing papers authored by James E. Dahlman

Since Specialization

Citations

This map shows the geographic impact of James E. Dahlman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Dahlman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Dahlman more than expected).

Fields of papers citing papers by James E. Dahlman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James E. Dahlman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Dahlman. The network helps show where James E. Dahlman may publish in the future.

Co-authorship network of co-authors of James E. Dahlman

This figure shows the co-authorship network connecting the top 25 collaborators of James E. Dahlman. A scholar is included among the top collaborators of James E. Dahlman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James E. Dahlman. James E. Dahlman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dahlman, James E., et al.. (2025). The effect of mRNA-lipid nanoparticle composition on stability during microneedle patch manufacturing. European Journal of Pharmaceutics and Biopharmaceutics. 215. 114819–114819. 1 indexed citations

Loughrey, David, et al.. (2025). The time course of in vivo cellular responses to LNPs. Chemical Communications. 61(23). 4535–4538. 1 indexed citations

Sanchez, Alejandro J. Da Silva, David Loughrey, Elisa Schrader Echeverri, et al.. (2024). Substituting Poly(ethylene glycol) Lipids with Poly(2‐ethyl‐2‐oxazoline) Lipids Improves Lipid Nanoparticle Repeat Dosing. Advanced Healthcare Materials. 13(17). e2304033–e2304033. 33 indexed citations

Huayamares, Sebastian G., Melissa P. Lokugamage, Alejandro J. Da Silva Sanchez, et al.. (2023). High-throughput screens identify a lipid nanoparticle that preferentially delivers mRNA to human tumors in vivo. Journal of Controlled Release. 357. 394–403. 45 indexed citations

Hincapie, Robert, Michael M. Baksh, Carlos Sanhueza, et al.. (2023). Multivalent Targeting of the Asialoglycoprotein Receptor by Virus‐Like Particles. Small. 19(52). e2304263–e2304263. 8 indexed citations

Lokugamage, Melissa P., Hyejin Kim, Curtis Dobrowolski, et al.. (2023). The Transcriptional Response to Lung-Targeting Lipid Nanoparticles in Vivo. Nano Letters. 23(3). 993–1002. 46 indexed citations

Madigan, Victoria J., Feng Zhang, & James E. Dahlman. (2023). Drug delivery systems for CRISPR-based genome editors. Nature Reviews Drug Discovery. 22(11). 875–894. 98 indexed citations breakdown →

Hatit, Marine Z. C., Curtis Dobrowolski, Melissa P. Lokugamage, et al.. (2023). Nanoparticle stereochemistry-dependent endocytic processing improves in vivo mRNA delivery. Nature Chemistry. 15(4). 508–515. 49 indexed citations

Hatit, Marine Z. C., Melissa P. Lokugamage, Curtis Dobrowolski, et al.. (2022). Species-dependent in vivo mRNA delivery and cellular responses to nanoparticles. Nature Nanotechnology. 17(3). 310–318. 93 indexed citations

10.

Ni, Huanzhen, Marine Z. C. Hatit, Kun Zhao, et al.. (2022). Piperazine-derived lipid nanoparticles deliver mRNA to immune cells in vivo. Nature Communications. 13(1). 4766–4766. 130 indexed citations breakdown →

11.

Miracle, D.B., et al.. (2021). Dataset of bond enthalpies (εAA, εAB, εBB) in 975 binary intermetallic compounds. SHILAP Revista de lepidopterología. 39. 107652–107652. 2 indexed citations

12.

Gan, Zubao, Melissa P. Lokugamage, Marine Z. C. Hatit, et al.. (2020). Nanoparticles containing constrained phospholipids deliver mRNA to liver immune cells in vivo without targeting ligands. Bioengineering & Translational Medicine. 5(3). e10161–e10161. 59 indexed citations

13.

Paunovska, Kalina, David Loughrey, Emmeline L. Blanchard, et al.. (2020). Increased PIP3 activity blocks nanoparticle mRNA delivery. Science Advances. 6(30). eaba5672–eaba5672. 21 indexed citations

14.

Lokugamage, Melissa P., Zubao Gan, Chiara Zurla, et al.. (2019). Mild Innate Immune Activation Overrides Efficient Nanoparticle‐Mediated RNA Delivery. Advanced Materials. 32(1). e1904905–e1904905. 94 indexed citations

15.

Paunovska, Kalina, David Loughrey, Cory D. Sago, Róbert Langer, & James E. Dahlman. (2019). Using Large Datasets to Understand Nanotechnology. Advanced Materials. 31(43). e1902798–e1902798. 47 indexed citations

16.

Sago, Cory D., et al.. (2018). Nanoparticles That Deliver RNA to Bone Marrow Identified by in Vivo Directed Evolution. Journal of the American Chemical Society. 140(49). 17095–17105. 108 indexed citations

17.

Sago, Cory D., et al.. (2018). Modifying a Commonly Expressed Endocytic Receptor Retargets Nanoparticles in Vivo. Nano Letters. 18(12). 7590–7600. 42 indexed citations

18.

Paunovska, Kalina, Carmen J. Gil, Melissa P. Lokugamage, et al.. (2018). Analyzing 2000 in Vivo Drug Delivery Data Points Reveals Cholesterol Structure Impacts Nanoparticle Delivery. ACS Nano. 12(8). 8341–8349. 130 indexed citations

19.

Sago, Cory D., et al.. (2018). Barcoding chemical modifications into nucleic acids improves drug stability in vivo. Journal of Materials Chemistry B. 6(44). 7197–7203. 18 indexed citations

20.

Dahlman, James E., Kevin Kauffman, Róbert Langer, & Daniel G. Anderson. (2014). Nanotechnology for In vivo Targeted siRNA Delivery. Advances in genetics. 88. 37–69. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact